immunotherapy drug candidate underwent phase human clinical trial cancer de novo protein first computationally designed institute protein design ipd university november neoleukin therapeutics announced would discontinue development predecessor first described published nature magazine january citizen science distributed computing project rosettahome based university washington contributed forward folding experiments helped validate protein designs developed neoleukin therapeutics biopharmaceutical company originated phase human clinical trial began may january neoleukin therapeutics announced collaboration merck combination clinical trial mercks pembrolizumab neoleukins november neoleukin therapeutics announced would discontinue development antineoplastic immunomodulatory drug article stub help wikipedia expanding